benzyl-alpha-n-acetylgalactosamine has been researched along with Stomach Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byrd, JC; Dahiya, R; Huang, J; Kim, YS | 1 |
| Adachi, M; Hayashi, T; Hinoda, Y; Imai, K; Itoh, F; Makiguchi, Y; Suwa, T; Takahashi, T | 1 |
2 other study(ies) available for benzyl-alpha-n-acetylgalactosamine and Stomach Neoplasms
| Article | Year |
|---|---|
Inhibition of mucin synthesis by benzyl-alpha-GalNAc in KATO III gastric cancer and Caco-2 colon cancer cells.
Topics: Acetylgalactosamine; Antigens, Tumor-Associated, Carbohydrate; Benzyl Compounds; Colonic Neoplasms; Humans; Mucins; Neoplasm Proteins; Oligosaccharides; Stomach Neoplasms; Tumor Cells, Cultured | 1995 |
Enhancement of reactivity of anti-MUC1 core protein antibody and killing activity of anti-MUC1 cytotoxic T cells by deglycosylation of target tissues or cells.
Topics: Acetylgalactosamine; Antigen-Antibody Reactions; Benzyl Compounds; Cell Line; Glycosylation; Humans; Immunohistochemistry; Mucin-1; Mucins; Neoplasm Proteins; Polysaccharides; RNA, Messenger; Stomach Neoplasms; T-Lymphocytes, Cytotoxic; Tumor Cells, Cultured | 1998 |